The invention relates to a microparticulate form of l-[2-(naphth-2-yl)ethyl]-4-(3-trifluoromethylphenyl)-l,2,3,6-tetrahydropyridine hydrochloride consisting of particles for which at least 55% of the population have a diameter below 50 micrometers, and to pharmaceutical compositions in which it is present.
展开▼
